Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study

We present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We includ...

Full description

Bibliographic Details
Authors: Kissling, E, Valenciano, M, I-MOVE Case-Control Studies Team, Jimenez-Jorge, Silvia, Mateo-Ontañon, Salvador de, Pozo Sanchez, Francisco, Ledesma, Juan, Casas Flecha, Inmaculada, Larrauri, Amparo
Format: article
Publication Date:2011
Country:España
Institution:Instituto de Salud Carlos III (ISCIII)
Repository:Repisalud
Language:English
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/15490
Online Access:http://hdl.handle.net/20.500.12105/15490
Access Level:Open access
Keyword:Disease Outbreaks
Adolescent
Adult
Aged
Case-Control Studies
Child
Europe
European Union
Female
Humans
Infant
Infant, Newborn
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Sentinel Surveillance
Treatment Outcome
Vaccination
Young Adult
id ES_339e93fdb85ed77688f53ff04cab2c2a
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/15490
network_acronym_str ES
network_name_str España
repository_id_str
spelling Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control studyKissling, EValenciano, MI-MOVE Case-Control Studies TeamJimenez-Jorge, SilviaMateo-Ontañon, Salvador dePozo Sanchez, FranciscoLedesma, JuanCasas Flecha, InmaculadaLarrauri, AmparoDisease OutbreaksAdolescentAdultAgedCase-Control StudiesChildEuropeEuropean UnionFemaleHumansInfantInfant, NewbornInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanMaleMiddle AgedSentinel SurveillanceTreatment OutcomeVaccinationYoung AdultWe present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: -7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine.European Centre for Disease Prevention and Control (ECDC)Unión Europea. European Centre for Disease Prevention and Control (ECDC)20232023-02-1020112011-03-1720112011-03-17research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/15490reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/154902026-06-12T12:43:37Z
dc.title.none.fl_str_mv Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
title Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
spellingShingle Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
Kissling, E
Disease Outbreaks
Adolescent
Adult
Aged
Case-Control Studies
Child
Europe
European Union
Female
Humans
Infant
Infant, Newborn
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Sentinel Surveillance
Treatment Outcome
Vaccination
Young Adult
title_short Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
title_full Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
title_fullStr Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
title_full_unstemmed Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
title_sort Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
dc.creator.none.fl_str_mv Kissling, E
Valenciano, M
I-MOVE Case-Control Studies Team
Jimenez-Jorge, Silvia
Mateo-Ontañon, Salvador de
Pozo Sanchez, Francisco
Ledesma, Juan
Casas Flecha, Inmaculada
Larrauri, Amparo
author Kissling, E
author_facet Kissling, E
Valenciano, M
I-MOVE Case-Control Studies Team
Jimenez-Jorge, Silvia
Mateo-Ontañon, Salvador de
Pozo Sanchez, Francisco
Ledesma, Juan
Casas Flecha, Inmaculada
Larrauri, Amparo
author_role author
author2 Valenciano, M
I-MOVE Case-Control Studies Team
Jimenez-Jorge, Silvia
Mateo-Ontañon, Salvador de
Pozo Sanchez, Francisco
Ledesma, Juan
Casas Flecha, Inmaculada
Larrauri, Amparo
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Unión Europea. European Centre for Disease Prevention and Control (ECDC)
dc.subject.none.fl_str_mv Disease Outbreaks
Adolescent
Adult
Aged
Case-Control Studies
Child
Europe
European Union
Female
Humans
Infant
Infant, Newborn
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Sentinel Surveillance
Treatment Outcome
Vaccination
Young Adult
topic Disease Outbreaks
Adolescent
Adult
Aged
Case-Control Studies
Child
Europe
European Union
Female
Humans
Infant
Infant, Newborn
Influenza A Virus, H1N1 Subtype
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Sentinel Surveillance
Treatment Outcome
Vaccination
Young Adult
description We present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: -7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine.
publishDate 2011
dc.date.none.fl_str_mv 2011
2011-03-17
2011
2011-03-17
2023
2023-02-10
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/15490
url http://hdl.handle.net/20.500.12105/15490
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv European Centre for Disease Prevention and Control (ECDC)
publisher.none.fl_str_mv European Centre for Disease Prevention and Control (ECDC)
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405758643240960
score 15,812429

Similar Items